Echogenic Exosomes as ultrasound contrast agents

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Ultrasound Imaging

Background:

• Exosomes are natural vesicles crucial for cell communication and biomolecule delivery.
• Their stability, biocompatibility, and low immunogenicity make them ideal for therapeutic delivery.
• Traditional microbubbles, effective ultrasound contrast agents, are limited by their large size and intravascular use.

Purpose of the Study:

• To develop echogenic exosomes by combining microbubble acoustic properties with exosome characteristics.
• To investigate the echogenicity and stability of these novel nanoparticles for ultrasound applications.
• To evaluate the in vivo performance of echogenic exosomes as ultrasound contrast agents.

Main Methods:

• Bovine milk-derived exosomes were rendered echogenic via freeze-drying with mannitol.
• Ultrasound imaging and scattered response measurements (linear and nonlinear) assessed echogenicity and stability.
• In vivo studies involved injecting echogenic exosomes into mice and rats for imaging.

Main Results:

• Echogenic exosomes significantly enhanced ultrasound image brightness (28.9% at 5 mg/mL, 40 MHz).
• Demonstrated substantial linear and nonlinear scattered responses (11 dB fundamental, 8.5 dB subharmonic, 3.5 dB second harmonic at 40 μg/mL).
• Achieved up to 300% brightness increase in vivo ultrasound images.

Conclusions:

• Echogenic exosomes serve as effective ultrasound contrast agents with enhanced imaging capabilities.
• Their properties (large-scale extractability, low toxicity, minimal immunogenicity) are advantageous.
• These nanoparticles offer potential as ultrasound-responsive drug delivery systems.